The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Enhancement of Insulin-Like Growth Factor Signaling in Human Breast Cancer: Estrogen Regulation of Insulin Receptor Substrate-1 Expression in Vitro and in Vivo
Open accessAbstract
Cross-talk between insulin-like growth factor (IGF)- and estrogen receptor (ER)-signaling pathways results in synergistic growth. We show here that estrogen enhances IGF signaling by inducing expression of three key IGF-regulatory molecules, the type 1 IGF receptor (IGFR1) and its downstream signaling molecules, insulin receptor substrate (IRS)-1 and IRS-2. Estrogen induction of IGFR1 and IRS expression resulted in enhanced tyrosine phosphorylation of IRS-1 after IGF-I stimulation, followed by enhanced mitogen-activated protein kinase activation. To examine whether these pathways were similarly activated in vivo, we examined MCF-7 cells grown as xenografts in athymic mice. IRS-1 was expressed at high levels in estrogen-dependent growth of MCF-7 xenografts, but withdrawal of estrogen, which decreased tumor growth, resulted in a dramatic decrease in IRS-1 expression. Finally, we have shown that high IRS-1 expression is an indicator of early disease recurrence in ER-positive human primary breast tumors. Taken together, these data not only reinforce the concept of cross-talk between IGF- and ER-signaling pathways, but indicate that IGF molecules may be critical regulators of estrogen-mediated growth and breast cancer pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
A Restriction Point for Control of Normal Animal Cell Proliferation
Pardee, A. B. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.4.1286 · Cited by 1,415
Autocrine Secretion and Malignant Transformation of Cells
Sporn, M. B., & Todaro, G. J. (1980) · New England Journal of Medicine · doi:10.1056/nejm198010093031511 · Cited by 1,346
Estrogenic Regulation of Growth and Polypeptide Growth Factor Secretion in Human Breast Carcinoma
DICKSON, R. B., & LIPPMAN, M. E. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-1-29 · Cited by 568
Prall, O. J., Sarcevic, B., Musgrove, E. A., Watts, C. W., & Sutherland, R. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10882 · Cited by 444
Laborda, J. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.14.3998 · Cited by 427
Umayahara, Y., Kawamori, R., Watada, H., Imano, E., Iwama, N., Morishima, T., Yamasaki, Y., Kajimoto, Y., & Kamada, T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34025-5 · Cited by 389
Stewart, A. J., Johnson, M. D., May, F. E., & Westley, B. R. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45342-7 · Cited by 381
Osborne, C. K., Coronado-Heinsohn, E. B., Hilsenbeck, S. G., McCue, B. L., Wakeling, A. E., McCleland, R. A., Manning, D. L., & Nicholson, R. I. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.10.746 · Cited by 361
Altucci, L., Addeo, R., Cicatiello, L., Dauvois, S., Parker, M., Truss, M., Beato, M., Sica, V., Bresciani, F., & Weisz, A. (1996) · PubMed · Cited by 343
Arteaga, C. L., Kitten, L. J., Coronado, E. B., Jacobs, S., Kull, F. C., Allred, D. C., & Osborne, C. K. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114315 · Cited by 328
Rubin, R., & Baserga, R. (1995) · PubMed · Cited by 311
Mechanism of estrogen activation of c-myc oncogene expression.
Dubik, D., & Shiu, R. P. C. (1992) · PubMed · Cited by 294
Kato, S., Tora, L., Yamauchi, J., Masushige, S., Bellard, M., & Chambon, P. (1992) · Cell · doi:10.1016/0092-8674(92)90148-6 · Cited by 289
The IRS‐signalling system during insulin and cytokine action
Yenush, L., & White, M. F. (1997) · BioEssays · doi:10.1002/bies.950190608 · Cited by 272
Biological differences among MCF-7 human breast cancer cell lines from different laboratories
Osborne, C. K., Hobbs, K., & Trent, J. M. (1987) · Breast Cancer Research and Treatment · doi:10.1007/bf01807363 · Cited by 272
Estrogen-Dependent Cyclin E-cdk2 Activation through p21 Redistribution
Planas-Silva, M. D., & Weinberg, R. A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.4059 · Cited by 267
Osborne, C. K., Coronado, E. B., Kitten, L. J., Arteaga, C. I., Fuqua, S. A. W., Ramasharma, K., Marshall, M., & Li, C. H. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-11-1701 · Cited by 248
Insulin-like growth factor II mRNA expression in human breast cancer.
Yee, D., Cullen, K. J., Paik, S., Perdue, J. F., Hampton, B., Schwartz, A. M., Lippman, M. E., & Rosen, N. X. (1988) · PubMed · Cited by 246
Krishnan, V., Wang, X., & Safe, S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40767-8 · Cited by 243
Daksis, J. I., Lu, R. Y., Facchini, L. M., Marhin, W. W., & Penn, L. Z. (1994) · PubMed · Cited by 227
Huynh, H., Yang, X., & Pollak, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.1016 · Cited by 219
KATZENELLENBOGEN, B. S., & JANE NORMAN, M. (1990) · Endocrinology · doi:10.1210/endo-126-2-891 · Cited by 185
Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells
Lee, A. V., Weng, C.-N., Jackson, J. G., & Yee, D. (1997) · Journal of Endocrinology · doi:10.1677/joe.0.1520039 · Cited by 182
Self-citationRocha, R. L., Hilsenbeck, S. G., Jackson, J. G., Berg, C. L. V. D., Weng, C., Lee, A. V., & Yee, D. (1997) · PubMed · Cited by 180
Self-citationJackson, J. G., White, M. F., & Yee, D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9994 · Cited by 171
Ruan, W., Catanese, V. M., Wieczorek, R. L., Feldman, M. L., & Kleinberg, D. L. (1995) · Endocrinology · doi:10.1210/en.136.3.1296 · Cited by 162
Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation.
Yang, X., Beamer, W. G., Huynh, H. T., & Pollak, M. (1996) · PubMed · Cited by 157
Philips, A., Chalbos, D., & Rochefort, H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85214-6 · Cited by 153
Guvakova, M. A., & Surmacz, E. (1997) · PubMed · Cited by 139
Growth regulation of human breast carcinoma occurs through regulated growth factor secretion
Lippman, M. E., Dickson, R. B., Gelmann, E. P., Rosen, N. X., Knabbe, C., Bates, S. E., Bronzert, D. A., Huff, K. K., & Kasid, A. (1987) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240350102 · Cited by 135
Richards, R. G., DiAugustine, R. P., Petrusz, P., Clark, G. C., & Sebastian, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.12002 · Cited by 127
Cullen, K. J., Lippman, M. E., Chow, D., Hill, S. M., Rosen, N. X., & Zwiebel, J. A. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.1.1310798 · Cited by 123
Type 1 IGF receptor in human breast diseases
Peyrat, J. P., & Bonneterre, J. M. (1992) · Breast Cancer Research and Treatment · doi:10.1007/bf01833334 · Cited by 115
The unliganded estrogen receptor (ER) transduces growth factor signals
Newton, C. J., Buric, R., Trapp, T., Brockmeier, S. J., Pagotto, U., & Stalla, G. K. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90197-x · Cited by 111
McGuire, W. L., Jackson, J. G., Figueroa, J. A., Shimasaki, S., Powell, D. R., & Yee, D. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.17.1336 · Cited by 107
Insulin-like growth factors and breast cancer
Lee, A., & Yee, D. (1995) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(96)82678-3 · Cited by 100
Self-citationCross-coupling between insulin and estrogen receptor in human neuroblastoma cells
Patrone, C., Ma, Z. Q., Pollio, G., Agrati, P., Parker, M. G., & Maggi, A. C. (1996) · Molecular Endocrinology · doi:10.1210/me.10.5.499 · Cited by 91
Mathieu, M. N., Vignon, F., Capony, F., & Rochefort, H. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-6-815 · Cited by 89
Transforming potential of the insulin receptor substrate 1.
D'Ambrosio, C., Keller, S. R., Morrione, A., Lienhard, G. E., Baserga, R., & Surmacz, E. (1995) · PubMed · Cited by 86
Regulation of insulin-like growth factor I receptor expression by the pure antiestrogen ICI 182780.
Huynh, H., Nickerson, T., Pollak, M., & Yang, X. (1996) · PubMed · Cited by 80
Differential roles of IRS-1 and SHC signaling pathways in breast cancer cells
Nolan, M. K., Jankowska, L., di Prisco, M., Xu, S., Guvakova, M. A., & Surmacz, E. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970904)72:5<828::aid-ijc20>3.0.co;2-3 · Cited by 72
Insulin-like growth factor receptors and binding proteins
LeRoith, D. (1996) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(96)80298-9 · Cited by 63
Identification of an alternate type I insulin-like growth factor receptor β subunit mRNA transcript
Yee, D., Lebovic, G. S., Marcus, R. R., & Rosen, N. X. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)88198-8 · Cited by 56
Daly, R. J., Harris, W. H., Wang, D. Y., & Darbre, P. D. (1991) · PubMed · Cited by 55
Freiss, G., Puech, C., & Vignon, F. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.4.0088 · Cited by 54
Antiestrogens increase protein tyrosine phosphatase activity in human breast cancer cells
Freiss, G., & Vignon, F. (1994) · Molecular Endocrinology · doi:10.1210/mend.8.10.7854356 · Cited by 50
Daws, M. R., Westley, B. R., & May, F. E. B. (1996) · Endocrinology · doi:10.1210/en.137.4.1177 · Cited by 33
Characterization and regulation of the mouse insulin receptor substrate gene promoter
Araki, E., Haag, B. L., Matsuda, K., Shichiri, M., & Kahn, C. R. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.10.8544845 · Cited by 31
Cited by
Obesity as a Major Risk Factor for Cancer
De Pergola, G., & Silvestris, F. (2013) · Journal of Obesity · doi:10.1155/2013/291546 · Cited by 959
Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women
Gunter, M. J., Hoover, D. R., Yu, H., Wassertheil-Smoller, S., Rohan, T. E., Manson, J. E., Li, J., Ho, G. Y. F., Xue, X., Anderson, G. L., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn415 · Cited by 563
Biology of Progesterone Receptor Loss in Breast Cancer and Its Implications for Endocrine Therapy
Cui, X., Schiff, R., Arpino, G., Osborne, C. K., & Lee, A. V. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.004 · Cited by 514
Self-citationSex-Based Differences in Skeletal Muscle Kinetics and Fiber-Type Composition
Haizlip, K. M., Harrison, B. C., & Leinwand, L. A. (2015) · Physiology · doi:10.1152/physiol.00024.2014 · Cited by 521
Estrogen Receptor α Rapidly Activates the IGF-1 Receptor Pathway
Kahlert, S., Nuedling, S., van Eickels, M., Vetter, H., Meyer, R., & Grohé, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910345199 · Cited by 474
Metadata
- Authors
- Lee, A. V.
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1999-05-01
- Volume
- 13
- Issue
- 5
- Pages
- 787-796
- ISSN
- 0888-8809 (ISSN-L)
- OpenAlex
- W2087729478
- Cited by
- 340
- References
- 50
- FWCI
- 12.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.